Health Archive » November, 2008

Health - November, 2008

156 articles

• Vaginal Deformity Claims To Proceed Against AMS
• Lilly Shoots Off 2 More Cymbalta Suits
• NationsHealth Workers Launch Unpaid Wage Action
• Complaints On Wyeth Outsourcing Led To Firing: Suit
• Avandia Bigger Heart Risk Than Competitor: Study
• StarCaps Diet Pill Recalled For Unauthorized Diuretic
• Providing For The Deaf, Hard Of Hearing Under ADA
• Barr, Mylan Face Patent Suit Over Amrix ANDAs
• Bayer Pays $97.5M To Settle Kickback Allegations
• Minn. Supreme Court To Weigh In On Prempro MDL
• Magistrate Rules On Motions In Crestor Patent MDL
• Roche, Apotex Drop One Patent In Spat Over Boniva
• EU Report To Target Drug Patents, Lawsuits
• AstraZeneca Settles Pulmicort War With Teva
• EU Raids Drug Cos. In Latest Antitrust Sting
• Aredia Judge Tosses More Failure-To-Warn Claims
• FDA Tells Cedax Maker To Fix Deceptive Marketing
• Reforms Part Of $925M UnitedHealth Deal
• J&J E-mails Link Research Center, Risperdal
• 'Exact' Match Not Needed To Show Age Bias: 6th Circ.
• Officials Warn Of Deaths Linked To Bayer Drug
• PharmaNet Stock Plunge Prompts Class Action
• Medtronic Loses Jury Trial Bid In Defibrillator Suit
• Skadden Tops List Of 2007 Litigation Revenue Makers
• FDA Warns Of Epilepsy Drug Danger For Asians
• Obama Could Raise Cap On H-1B Skilled Workers
• GSK Parent Off The Hook In Paxil Birth Defect Suit
• Abbott, WARF Clash With Teva Over Zemplar
• Quigley Urges Court To Overrule Insurance Protests
• Barr Settles With CVS, Walgreen But Not Meijer
• Lane Powell Ordered Off CellCyte Investor Suit
• McKesson Agrees To Settle AWP Case For $350M
• Calif. Supreme Court To Consider 'Pass-On' Defense
• Fed. Circ. Reverses Ruling In IV Patent Dispute
• Bracing For The Surge In Reimbursement Disputes
• GSK Ordered To Produce Paxil Ad Campaign Details
• Pfizer Wins Choice-Of-Law Appeal In Lipitor Actions
• Cryomed Sued For Infringement, Defamation
• Roche Vows To Appeal $12.9M Accutane Verdict
• AstraZeneca Scores TRO Against Teva
• Eli Lilly, Princeton Fire Off Another Alimta Suit
• EU Calls For Suspension Of J&J's Ionsys
• Arthrex Hit With Injunction In Suture Anchor Suit
• Tort Costs Climbed $5.1B In '07: Report
• Waxman Bumps Dingell From Energy Committee Chair
• Abbott Settles TriCor Class Action For $184M
• ERISA Doesn't Preempt Contract Dispute: 9th Circ.
• Sanofi Victorious In Arava Antitrust Class Action
• Anticipating Obama's Consumer Protection Push
• Avastin-Chemo Combo Could Boost Clot Risk: Study
• Sanofi To Get $60M In Allegra Deal With Barr, Teva
• Class Action Rise Paints Complex Picture
• Wyeth Asks For Delay In Patent Fight With Apotex
• Nev. Sues Wyeth, Pfizer Over Hormone Drugs
• Sun Pharma Fires Back At Biovail In Cardizem Suit
• FDA Opens 3 Offices In China
• AstraZeneca, Teva Patent Spat Flares Up
• Wyeth, Cordis Add Abbott To Medtronic Stent Spat
• Novartis Spars With Sales Reps Over FLSA Exemptions
• 1st Circ. Upholds NH Law On Prescription Data
• USPTO Works Record Number Of Patent Apps In FY08
• Boehringer Sues To Block Norbrook's Generic Metacam
• Lilly Targets Actavis In Latest Cymbalta Patent Suit
• Jury Tags J&J Units To Pay $16M For Pain Patch Death
• 3rd-Party Funding Fuels European Litigation Growth
• Plavix: A Significant Decision For Patent Holders
• Schering Sues Sun, Caraco Over New Clarinex Patent
• Eli Lilly Circles Wagons Around Cymbalta Patent
• DOJ Subpoenas Medtronic Over Bone Graft Product
• Alpharma Sues Purdue Over Painkiller Mktg. Rights
• 5th Circ. Rebuffs Insurers In Vioxx Settlement
• GSK Wins Bid To Boot Paxil Suicide Suit
• Lawmakers Probe FDA Over Medical Device Review
• FDA Seeks Panel Expert Review Of Antibiotic
• DOL Expands Family Leave, Adds Worker Limits
• Teva, Zydus Drop Some Claims In Coreg Patent Suit
• Pozen Sues Par Pharmaceutical Over Migraine ANDA
• Teva Contests 2 Of Gilead's Truvada Patents
• DOJ Takes Aim At Actavis' Drug-Making Practices
• Pfizer Seeks To Limit Discovery In Quigley Ch. 11
• SEC Charges Ex-McKesson Exec With Insider Trading
• 4 Novartis Claims Dropped In Retisert Sales Spat
• Texas Asbestos MDL Wants Defeated Judge To Stay
• Judge Rejects Class Cert. In Crest Mouthwash Case
• Judge Keeps One Claim Alive In DOL Info Suit
• Univ. Of Kansas Sues NIH Over Cancer Drug Patents
• McKesson Manager Disgorges Insider Trading Spoils
• US Attorneys' Offices' Resources Mismanaged: Audit
• Orion Strikes At Sun Over Comtan ANDA
• Ousted Chairman Considers Suing Cohen Milstein
• Synthes Brandishes Patent Against Implant Maker
• EU Raids French Biomedical Analysis Firms
• Roche, Mutual Drop Part Of Suit Over Boniva
• Bone Drugs Pose No Clear Threat To Heart: FDA
• Woman Slaps Pfizer With Lawsuit Over PCBs
• Tort Victims Challenge Privilege In Quigley Ch. 11
• FDA Eyes Alpharma's Embeda Over Abuse Effects
• In Perspective: Federal Agency Standards Preemption
• Accentia Seeks Ch. 11 Shelter, Blames Credit Crunch
• Nursing Facility Transparency And Congress
• Oticon Gives Rivals Earful Over Hearing Aid Patent
• Dickstein Hires Former DuPont Counsel Mobley
• Quality Of Care Issues For Providers
• Katz Inks Licensing Deals With 10 More Cos.
• Hope At Last For Drug Manufacturers Sued In NJ?
• Looking At The Future Of Preemption
• Drug Co. Sues USPTO Over Patent Term Adjustment
• Mo. Right Venue For Teva Amoxicillin Suit: Judge
• CR Bard Falls Short In Bid To Nullify Class
• Antitrust Claims V. US Dept. Of Health Barred: Judge
• Forest Labs To Settle Shareholders' Suit For $65M
• SRU's 31 Sensor Patents Invalid, Sensor Maker Claims
• Court Denies Lilly Depositions In Zyprexa MDL
• Ethex Issues Another Recall Of Oversize Pills
• Baltimore Targets McKesson For AWP Markups
• Nucletron To Settle EEOC Age Bias Claim For $295K
• Wyeth Can Be Liable For Generic Warnings: Court
• Consolidated 3rd-Party Payer Seroquel Case Tossed
• Axed Cohen Milstein Partner Starts Hausfeld LLP
• Teva Hears No Again In Risperdal Spat
• Bayer Sues Norbrook Over Bid For Livestock Drug
• Innovator's Guide To Navigating CMS
• Teva's Bid To Crack Attorney-Client Privilege Fails
• Wyeth, Pfizer Face More Claims In Premarin Suit
• Obama's FDA Commissioner Pick Could Be Outsider
• Fed. Circ. Upholds Bar On Generic Prevacid For Teva
• Teamwork, Turf Wars For State AGs Under Obama
• Slashed Fees For McDermott In St. Vincent's Suit OK'd
• Willfulness Claims Stricken In 4 ADHD Drug Suits
• Hammill Sues Over Bone Screw Claims
• FDA Takes Contaminated Heparin From Ohio Drug Co.
• Canada High Court Upholds Plavix 'Selection' Patent
• Baby Formula Makers' Case Transfer Request Denied
• Impax Sued Again Over Ultram ANDA
• Wyeth Settles With 4th Drug Co. Over Generic Effexor
• Asbestos Victims Demand Voice In Quigley Case
• 471,000 Mislabeled Insulin Syringes Recalled
• FDA Enforcement May Soon Extend To Tobacco
• Calif. Fertility Clinic Hit With FDA Warning
• Plaintiff Bid To Disband Baycol MDL Nixed
• 9th Circ. Denies Dismissal To HBOC Fraud Defendants
• Abbott Sues Biovail Over Generic TriCor
• NuvaRing MDL Defendants Seek Master Complaint
• FDA Warns Caraco Over Violations At Drug Plant
• DOJ, State AGs Investigate Vytorin Marketing
• Judge: Corepharma Did Not Infringe Carbatrol Patent
• Sheppard Mullin Lands 13th Heller Partner For Year
• Roche Wins Judgment In Accutane Suicide Case
• Court Says Hospitals Can Be Sued Over Contractors
• Wyeth V. Levine In Light Of Merck's Vioxx Litigation
• Genetic Researchers Clash Over Diagnostic Patents
• Cephalon Sues Barr Again Over Generic Fentora ANDA
• Omnicare Faces 2 Qui Tam Antitrust Fraud Suits
• DOJ Eyes AtriCure Over Marketing Practices
• Rotech Healthcare Sues Rival For Wooing Employees
• Future Product Liability Law In Hands Of High Court